BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 26, 2021
View Archived Issues
Neuron-specific delivery platform based on a chimeric toxin for botulism postexposure treatment
Read More
Incyte initiates phase I/II study of INCB-000928 in patients with anemia due to MF
Read More
Phase I trial investigates NNC0361-0041 for type 1 diabetes
Read More
Study links ALS gene to tumor suppressor, transcription changes
Read More
Membrane rupture is active event
Read More
Xarelto approved in Japan to treat children with VTE and to prevent VTE recurrence
Read More
Exelixis initiates first-in-human study of XL-102 in advanced or metastatic solid tumors
Read More
Bavencio approved in Europe as first-line maintenance for urothelial carcinoma
Read More
UCB patents dopamine D1 receptor PAMs
Read More
Roche synthesizes MGL inhibitors
Read More
Progen presents new fusion proteins for autoimmune diseases
Read More
Chinese researchers present CAR T-cell therapy for cancer
Read More
AR agonist-based strategy proposed for ER+ breast cancer
Read More
Zymso approved in Japan for interstitial cystitis
Read More
Merck & Co. discontinues development of V-590 and V-591 vaccine candidates
Read More
New NFE2L2 activators patented by Senju Pharmaceutical
Read More
Dosing begins in phase II study of MVC-COV-1901 vaccine in Taiwan
Read More
StemVacs induces regression of glioma, lung and colorectal cancer tumors in vivo
Read More
Ivermectin use tied to lower mortality in patients with COVID-19
Read More
5-HT2B as a novel therapeutic target to improve microstructural remodeling post-MI
Read More
Dosing begins in phase I study of TJ-210 in advanced solid tumors
Read More
Rinvoq approved in E.U. for psoriatic arthritis and ankylosing spondylitis
Read More
Curadigm's Nanoprimer-based project selected for Sanofi iTech Awards program
Read More
One-year data from SPIRIT Extension study of relugolix combination therapy in endometriosis
Read More